4D)

4D). The concentrations of clone 11-containing ICs used above induced maximum B cell proliferation, perhaps masking the effects of IFN- priming within the response of B cells to suboptimal BCR signals. of systemic lupus erythematosus (SLE). == Intro == Systemic lupus erythematosus (SLE) and additional autoimmune diseases are characterized by the development of autoantibodies directed against a limited subset of nucleic acid-containing antigens including DNA, chromatin, and ribonucleoproteins (1). Problems in the clearance of apoptotic material have been GNF179 Metabolite associated with the development of anti-nuclear antibodies and autoimmune disease (2). However, the mechanism leading to the production of DNA-reactive autoantibodies is definitely difficult to explain since mammalian DNA is definitely a poor immunogen compared to microbial DNA (3-5). We have previously demonstrated that ICs comprising mammalian DNA can very efficiently activate IgGautoreactive B cells through a mechanism dependent on engagement of the BCR and the intracellular pattern-recognition receptor TLR9 (6). TLR9 was originally identified as a sensor for microbial DNA, through its acknowledgement of unmethylated CpG motifs found at a high rate of recurrence in microbial DNA (7). By contrast, mammalian DNA has a low GC-content, is definitely depleted for CpG dinucleotides, and is highly methylated (8). The requirement for CpG dinucleotides in immunostimulatory DNAs was first demonstrated in studies examining synthetic phosphodiester linked oligonucleotides (PDODNs) (9,10). Subsequent studies examining short synthetic phosphorothioate oligonucleotides (PS-ODNs) led to the recognition of PuPuCGPyPy as the optimal motif for effective engagement of mouse TLR9 (11). However a series of recent studies possess questioned how well these PS-stabilized CpG motifs reflect authentic microbial and/or endogenous ligands. For example, when used at exceedingly high concentrations, phosphodiester-linked (PD) non-CpG ODNs can have stimulatory activity (12-14). Moreover, total mammalian DNA was reported to efficiently activate a TLR9 fusion protein expressed on the surface of transfected HEK 293 cells GNF179 Metabolite (15), and total mammalian DNA complexed with the anti-microbial peptide LL37 was found to stimulate plasmacytoid dendritic cells (16). In addition, PD-ODNs were recently reported to activate dendritic cells through a sequence self-employed, backbone-dependent mechanism (17). However, the importance of mammalian DNA CpG content material in the activation of TLR9, and in particular in the activation of autoreactive B cells, remains unresolved; either the relative activities of CpG-rich and non-CpG rich mammalian DNA have not been accurately compared or experimental systems are used that depend within the delivery of DNA by the addition of a 3-poly G tail to push aggregation (18) or by artificial delivery to early endosomes with the transfection reagent DOTAP (14). These data are inconsistent with our personal observations, which focused on the more physiologically relevant uptake of autoantigen-containing ICs by either the BCR or FcRs (19,20). By using dsDNA fragments approximately 600 bp in length that either did or did not incorporate canonical CpG motifs, we clearly demonstrated a critical part for unmethylated CpG motifs in the activation of autoreactive B cells, and found that total mammalian DNA experienced only fragile activity (19). Although high-dose non-CpG ligands may have the capacity to result in TLR9 TFR2 in certain experimental systems, studies including receptor-mediated uptake are the most relevant to the study of autoimmune disease, as they best recapitulate the route through which self-DNA normally accesses TLR9. In addition, apoptotic nucleosomal DNA GNF179 Metabolite larger than 200 bp is definitely hypothesized to become the self-DNA ligand (6,19), and DNA with this size range is definitely, by itself, taken up inefficiently by B cells compared to short ODNs. Importantly, concentrations of DNA at or below those found in the sera of individuals with autoimmune disease (50-250 ng/ml (21)) can activate B cells if taken up via the BCR. In contrast, many of the experimental systems discussed above use concentrations of DNAs GNF179 Metabolite 100-1000 fold higher, probably obscuring the requirements for TLR9 acknowledgement during the course of autoimmune disease. Given the dependence for CpG-rich DNA and the inability of total mammalian DNA to efficiently activate TLR9 in our model system, we have now asked if specific elements of mammalian DNA, namely CpG islands, can preferentially activate B cells through a TLR9-dependent mechanism. CpG islands are regions of the genome that are GC-rich (50-80% GC), not depleted for CpG dinucleotides relative to the rest of the genome, and generally unmethylated (22). CpG islands consequently constitute an endogenous source of CpG-rich DNA, even though the rate of recurrence of canonical CpG motifs is definitely relatively low. Our data demonstrate that CpG island dsDNA fragments, in contrast to CpG-poor dsDNA fragments, are amazingly potent TLR9 ligands. In addition, we found that the BCR of DNA-reactive B cells selectively.